Xilio Therapeutics (XLO) Current Leases (2020 - 2026)
Xilio Therapeutics (XLO) posted Current Leases of $1.4 million for Q1 2026, up 3.05% sequentially from $1.3 million in Q4 2025, and up 12.89% YoY from $1.2 million in Q1 2025.
Xilio Therapeutics (XLO) Current Leases (2020 - 2026) Analysis & Trends
Xilio Therapeutics has reported Current Leases for 7 years, with the latest figure at $1.4 million in Q1 2026.
- Quarterly Current Leases rose 12.89% year-over-year to $1.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 million (up 12.89% YoY) and the FY2025 annual result came in at $1.3 million, up 13.05% from the prior year.
- Current Leases improved to $1.4 million in Q1 2026 per XLO's latest filing, from $1.3 million in the prior quarter.
- Over five years, Current Leases peaked at $1.4 million in Q1 2026 and troughed at $829000.0 in Q1 2022.
- A 5-year average of $1.1 million and a median of $1.1 million in 2024 frame the typical range for Current Leases.
- The sharpest annual moves came in 2022 and 2026: Current Leases increased 14.88% in 2022, then climbed 12.89% in 2026.
- Over 5 years, Current Leases stood at $918000.0 in 2022, then rose by 14.05% to $1.0 million in 2023, then gained by 13.47% to $1.2 million in 2024, then grew by 13.05% to $1.3 million in 2025, then rose by 3.05% to $1.4 million in 2026.
- According to Business Quant data, Current Leases over the past three periods registered $1.4 million, $1.3 million, and $1.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Leases (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 720.00 Mn |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | - |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 21.95 Mn |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 45.93 Mn |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | 6.27 Mn |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | - |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | - |
| 10 | Xilio Therapeutics | 177.75 Mn | 41.71 Mn | - | 1.43 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.43 Mn |
| Mar 31, 2026 | 1.38 Mn |
| Dec 31, 2025 | 1.34 Mn |
| Sep 30, 2025 | 1.30 Mn |
| Jun 30, 2025 | 1.26 Mn |
| Mar 31, 2025 | 1.23 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 1.15 Mn |
| Jun 30, 2024 | 1.12 Mn |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 1.05 Mn |
| Sep 30, 2023 | 1.01 Mn |
| Jun 30, 2023 | 981,000.00 |
| Mar 31, 2023 | 949,000.00 |
| Dec 31, 2022 | 918,000.00 |
| Sep 30, 2022 | 888,000.00 |
| Jun 30, 2022 | 858,000.00 |
| Mar 31, 2022 | 829,000.00 |
| Dec 31, 2021 | 801,000.00 |
| Sep 30, 2021 | 773,000.00 |